drugset / Trial / NCT05018013

Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression

NCT05018013

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of Ammoxetine hydrochloride enteric-coated tablets in subjects with depression.

Timeline

Start
2021-08-21
Primary completion
2022-08-01
Completion
2022-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ammoxetine Unknown
Comparator Duloxetine Small molecule